We are helping build a future where no one dies from skin cancer
Skin Analytics are working with the NHS to build world leading skin cancer pathways using the only Class III CE marked AI as a Medical Device for skin cancer to sustainably deliver better patient outcomes
Proud to partner with the NHS since 2020
Shortage of NHS dermatologists and growing waitlists
Skin cancer referrals have nearly tripled over the last decade [1]. At the same time, 1 in 4 Consultant Dermatologist posts remain unfilled [2]. Despite sustained and considerable effort from dermatology departments, waitlists have doubled over the last half-decade and over 400,000 patients are waiting to be seen [3].
Skin Analytics’ Class III CE marked AI as a Medical Device (AIaMD), DERM (Deep Ensemble for the Recognition of Malignancy), is built around our custom built teledermatology platform to help triage patients into the right place, at the right time and to conserve dermatologist capacity for patients who need it.
DERM safely triages patients with non-cancerous lesions away from cancer pathways, allowing dermatologists to focus on the patients that need them most.
The world’s most advanced AI skin cancer pathways
NHS nurtured, global leader
Supported by the NHS since 2016 as part of the NHS accelerators DigitalHealth.London and the NHS National Innovation Accelerator as well as through the AI in Health & Care Award and SBRI Healthcare Cancer Programme
99.5%
accurate ruling out of skin cancer
Skin Analytics
Performance Reports
20-40%
discharge of USC pathway patients
Skin Analytics
Performance Reports
55-65%
patients avoid USCR in primary care
Skin Analytics
Performance Reports
Find out more
If you would like to know more about how Skin Analytics can help you and your dermatology team deliver best in class dermatology, get in touch.